(RE)EXISTÊNCIAS E O PROCESSO DE PLANEJAMENTO DE SEQUÊNCIAS DIDÁTICAS

O presente relato de experiência tem como objetivo geral apresentar as reflexões construídas por bolsistas do Programa Institucional de Iniciação à Docência – PIBID, subprojeto Letras LP, durante o processo de planejamento e desenvolvimento de sequência didática visando o trabalho com o gênero microconto sob uma perspectiva baseada em letramentos de reexistência em uma turma do 8° ano do Fundamental II da Escola de primeiro grau Jesus Cristo. Para o desenvolvimento deste trabalho, assentamos o nosso referencial teórico-metodológico em Marcuschi (2008), quanto aos gêneros textuais; Freire (1970) e sua abordagem emancipatória da educação, Souza (2011); para questões acerca dos Letramentos de reexistência e Multiletramentos,  Dolz, Noverráz e Schneuwly (2004), sobre o planejamento de módulos de sequência didática. Desta forma, este trabalho relata os procedimentos e o processo de planejamento de sequência didática numa turma de 8° ano.

Adjunctive Antiseptic Irrigation of Periodontal Pockets: Effects on Microbial and Cytokine Profiles

To evaluate the effect of adjunctive antiseptic irrigation of periodontal pockets on microbial and cytokine profiles. Fifty-nine patients with severe periodontitis were allocated to one of three groups for scaling and root planing facilitated with different adjunctive antiseptics: 1% polyhexamethyleneguanidine phosphate (PHMG-P) (n = 19), 0.2% chlorhexidine (CHX) (n = 21) or distilled water (n = 19). Gingival crevicular fluid and subgingival bacterial samples were collected at baseline, and at 2 weeks, and 1 and 4 months. The levels of interleukin (IL)-1β, IL-8, IL-10, and IL-17A, matrix metalloproteinase (MMP)-8, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum,Aggregatibacter actinomycetemcomitans, and Prevotella intermedia were determined. There were no intergroup differences in cytokine concentrations and bacterial counts at any follow-up, however, varying patterns were observed. In the PHMG-P and water groups IL-1β expression peaked at 2 weeks and then gradually declined. In all three groups, the dynamics of MMP-8 concentration were non-linear, increasing by 2 weeks and then declining to below baseline (p > 0.05). P. gingivalis and T. forsythia declined within the first month and increased thereafter, not regaining the baseline level. Adjunctive antiseptic treatment was associated with changes in biomarkers and bacterial counts in the course of the study. The effects of adjunctive antiseptic irrigation were limited in the applied protocol

Adjunctive Antiseptic Irrigation of Periodontal Pockets: Effects on Microbial and Cytokine Profiles

To evaluate the effect of adjunctive antiseptic irrigation of periodontal pockets on microbial and cytokine profiles. Fifty-nine patients with severe periodontitis were allocated to one of three groups for scaling and root planing facilitated with different adjunctive antiseptics: 1% polyhexamethyleneguanidine phosphate (PHMG-P) (n = 19), 0.2% chlorhexidine (CHX) (n = 21) or distilled water (n = 19). Gingival crevicular fluid and subgingival bacterial samples were collected at baseline, and at 2 weeks, and 1 and 4 months. The levels of interleukin (IL)-1β, IL-8, IL-10, and IL-17A, matrix metalloproteinase (MMP)-8, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum,Aggregatibacter actinomycetemcomitans, and Prevotella intermedia were determined. There were no intergroup differences in cytokine concentrations and bacterial counts at any follow-up, however, varying patterns were observed. In the PHMG-P and water groups IL-1β expression peaked at 2 weeks and then gradually declined. In all three groups, the dynamics of MMP-8 concentration were non-linear, increasing by 2 weeks and then declining to below baseline (p > 0.05). P. gingivalis and T. forsythia declined within the first month and increased thereafter, not regaining the baseline level. Adjunctive antiseptic treatment was associated with changes in biomarkers and bacterial counts in the course of the study. The effects of adjunctive antiseptic irrigation were limited in the applied protocol

Efeito da temporada de basquetebol profissional sobre o perfil lipídico

The aim of the present study was to verify the effect of the professional basketball season on the lipids profile. Seven professional players (age: 23.6±4.3 years; body mass: 110.2±17.5 kg; height: 195.4±10.3 cm) were evaluated before and after a period ranging 4 moths, during national professional basketball season (2 games per week, 2 to 3 tactical and technical exercise workout, 2 to 3 strength exercise workout, 1 to 2 recuperative workout and 1 day of passive rest, all of then as a median per week). Blood samples and anthropometric measures were taken. The first visit was made before the beginning of the season and the second visit two days (48 hours) after the ending of the last game of the season. The lipids profile (triglyceride, VLDL, LDL-cholesterol, HDL-cholesterol, and total cholesterol) was analyses by commercial kits (Labtest®, Brazil). The comparison between the results (before and after) was carried through by non-parametric Wilcoxon pair test. The level of significance of 5% was used (p < 0.05). After basketball season, a reduction in the LDL-cholesterol plasma concentrations was demonstrated (before: 111.40±9 mg/dL after: 84.60±8.50 mg/dL; p < 0.05), as well as in total cholesterol (before: 171.20±6.44 mg/dL after: 148.20±6.37 mg/dL; p < 0.05). Besides, increase in rate the HDL/total cholesterol was found (before: 0.22±0.03 after: 0.27±0.06; p < 0.05). The results herein found indicate that the basketball season may induce changes in LDL-cholesterol, total cholesterol and in rate the HDL/total cholesterol concentrations, suggesting a modulatory effect on the lipid profile in professional basketball player after 4 moths season.O objetivo do presente estudo foi verificar o efeito da temporada de basquetebol profissional sobre o perfil lipídico. Sete jogadores profissionais (idade: 23,6±4,3 anos; massa corporal: 110,2±17,5 kg; estatura: 195,4±10,3 cm) foram avaliados antes e após um período de 4 meses, relativos a uma temporada nacional de basquetebol profissional (2 partidas por semana, 2 a 3 sessões de treinos técnicos e tático, 2 a 3 sessões de treino de musculação, 1 a 2 sessões de treino regenerativo e 1 dia de descanso passivo, sendo todos a média por semana) . Os jogadores foram submetidos a analise antropométrica e coleta sangüínea. A primeira visita foi feita antes do início da temporada e a segunda visita dois dias (48 horas) após o término da última partida da temporada. Foram realizadas análises do perfil lipídico (triacilglicerol, VLDL, LDL-colesterol, HDL-colesterol, e colesterol total) por kits comerciais (Labtest®, Brasil). A comparação entre os resultados foi realizada pareadamente (antes e depois o início da temporada) por teste não paramétrico de Wilcoxon. Utilizou-se o nível de significância de 5% (p < 0,05). Após a temporada, foi demonstrada diminuição nas concentrações da LDL-colesterol (pré: 111,40±9 mg/dL vs pós: 84,60±8,50 mg/dL; p < 0,05), bem como do colesterol total (pré: 171,20±6,44 mg/dL vs pós: 148,20±6,37 mg/dL; p < 0,05). Além disso, foi encontrado aumento na taxa HDL/colesterol total (pré: 0,22±0,03 vs pós: 0,27±0,06; p < 0,05). Os resultados indicam que a temporada de basquetebol profissional pode induzir alterações na concentração de LDL-colesterol, de colesterol total e na taxa HDL/colesterol total, sugerindo um efeito modulador sobre o perfil lipídico de jogadores profissionais de basquetebol após uma temporada de 4 meses

Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study

Vedolizumab, a gut-specific biological treatment for inflammatory bowel disease (IBD), is an antibody that binds to the α4β7 integrin and blocks T-cell migration into intestinal mucosa. We aimed to investigate chemokine levels in serum of IBD-patients treated with vedolizumab. In this pilot study, we included 11 IBD patients (8 Crohn’s disease, 3 ulcerative colitis) previously non-respondent to anti-tumor necrosis factor (TNF)-agents. Patients received vedolizumab at week 0, 2 and 6 and were evaluated for clinical efficacy at week 10. Clinical characteristics and routine laboratory parameters were obtained and patients were classified as responders or non-responders. Expression of 21 chemokines in serum was measured using Proximity Extension Assay and related to clinical outcome. At week 10, 6 out of 11 patients had clinically responded. Overall expression of CCL13 increased after treatment. In non-responders, expression of CCL13 and CXCL8 increased after treatment, and CCL20 and CXCL1 expressions were higher compared to responders. In responders, CCL28 decreased after treatment. C-reactive protein (CRP) correlated negatively with 6 chemokines before therapy, but not after therapy. Systemic CCL13 expression increases in IBD-patients after vedolizumab therapy and several chemokine levels differ between responders and non-responders. An increased CCL13-level when starting vedolizumab treatment, might indicate potential prognostic value of measuring chemokine levels when starting therapy with vedolizumab. This study provides new information on modulation of systemic chemokine levels after vedolizumab treatment

Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus

Background Laboratory tests of blood and sometimes urine are used to diagnose and to monitor disease activity (DA) in SLE. Clinical practice would be simplified if non-invasive urine and salivary tests could be introduced as alternatives to blood samples. We therefore explored the levels of innate immunity-related biomarkers in matched serum, urine and saliva samples from patients with SLE. Methods A total of 84 patients with SLE selected to represent high and low general DA, and 21 controls were included. All participants underwent a thorough clinical examination. General DA and renal DA were measured. The levels of colony-stimulating factor (CSF)-1, interleukin (IL)-34, tumour necrosis factor (TNF)-alpha, interferon-gamma-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, calprotectin, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta were analysed by immunoassays and related to DA. Results CSF-1, TNF-alpha, IP-10 and MCP-1 in saliva, serum and urine, as well as calprotectin in saliva and urine were increased in patients with SLE as compared with controls (p&lt;0.05). TNF-alpha, IP-10 and MCP-1 in saliva, serum and urine, and CSF-1 in saliva and serum distinguished patients with SLE from controls (area under the curve &gt;0.659; p&lt;0.05 for all). CSF-1 in serum and urine, and calprotectin in saliva and urine, as well as TNF- alpha, IP-10 and MCP-1 in urine correlated positively with measures of general DA (p&lt;0.05). Patients with SLE with active renal disease presented elevated levels of TNF-alpha, IP-10 and MCP-1 in urine and CSF-1 and IP-10 in serum as compared with patients with SLE with non-active renal disease. Conclusions Our investigation demonstrates that saliva is a novel alternative body fluid, with potential for surveillance of general DA in patients with SLE, but urine is more informative in patients with SLE with predominantly renal DA

Salivary microbial profiles in relation to age, periodontal, and systemic diseases

Background Analysis of saliva is emerging as a promising tool to diagnose and monitor diseases which makes determination of the salivary microbial profile in different scenarios essential. Objective To evaluate the effects of age, periodontal disease, sex, smoking, and medical conditions on the salivary microbial profile. Design A randomly selected sample of 441 individuals was enrolled (51% women; mean age 48.5 +/- 16.8). Participants answered a health questionnaire and underwent an oral examination. Stimulated saliva was collected and the counts of 41 bacteria were determined by checkerboard DNA-DNA hybridization. Results Elderly participants (>64 years old) presented a significant increase in 24 out of 41 bacterial species compared to adults (<= 64 years old). Eubacterium nodatum, Porphyromonas gingivalis, and Tannerella forsythia were significantly higher in participants with generalized bone loss compared to without. Males and non-smokers had higher bacteria counts in saliva. Individuals having mental disorders or muscle and joint diseases showed significantly altered microbial profiles whereas small or no differences were found for subjects with high blood pressure, heart disease, previous heart surgery, bowel disease, tumors, or diabetes. Conclusion Age, periodontal status, sex, smoking, and certain medical conditions namely, mental disorders and muscle and joint diseases, might affect the microbial profile in saliva

Colony stimulating factor-1 in saliva in relation to age, smoking, and oral and systemic diseases

Colony stimulating factor (CSF)-1 is a growth factor that stimulates the survival, proliferation and differentiation of mononuclear phagocytes, which has been implicated in several inflammatory diseases. This study evaluated the possible influence of age, sex, smoking, periodontitis, caries, and several systemic conditions on salivary levels of CSF-1. Four-hundred and forty-one individuals were enrolled in this study. All participants answered a health questionnaire and underwent a comprehensive oral examination. Stimulated saliva was collected and CSF-1 levels were analysed by enzyme-linked immunosorbent assay. Salivary levels of CSF-1 were significantly increased in participants over 64 years old and in non-smoking individuals, whereas no difference was observed between men and women. Individuals having periodontitis and manifest caries had significantly higher levels of CSF-1. Participants with muscle and joint disease exhibited increased CSF-1 levels as compared to those without. Age, smoking, percentage of pockets >= 4 mm, number of manifest caries lesions, and presence of tumor were associated with CSF-1 levels. Salivary levels of CSF-1 are associated with age, smoking, periodontitis, manifest caries, and the presence of muscle and joint diseases and tumors. CSF-1 might be a promising biomarker candidate in saliva of both local and systemic conditions that needs further investigation

Salivary and Serum Markers Related to Innate Immunity in Generalized Aggressive Periodontitis

WOS: 000416136900013PubMed ID: 28753101Background: Host inflammatory and immune responses play an important role in aggressive periodontitis (AgP). Thus, this study aims to evaluate levels of the innate immunity-related markers calprotectin, colony-stimulating factor (CSF)-1, macrophage migration inhibitory factor (MIF), monokine induced by interferon-gamma (MIG), and matrix metalloproteinase (MMP)-8 in serum and saliva from patients with generalized AgP and those with gingivitis or a healthy periodontium. Methods: This study enrolled 40 individuals (17 males and 23 females; mean age 33.30 +/- 9.31 years), 15 with generalized AgP, 15 with gingivitis, and 10 who were periodontally healthy. Full-mouth periodontal examinations were performed, and serum and saliva were collected. Levels of calprotectin, CSF-1, MIF, MIG, and MMP-8 were measured using enzyme-linked immunosorbent assays. Results: In serum, mean levels of calprotectin were 2.06-fold higher in patients with AgP than in healthy patients (P = 0.01). Serum levels of MMP-8 were significantly elevated in patients with AgP compared with both healthy patients and those with gingivitis, by 2.60-fold and 2.77-fold, respectively (P = 0.03 and P = 0.009, respectively). In saliva, levels of MMP-8 were 5.66-fold higher in patients with AgP than in healthy patients (P = 0.02). CSF-1, MIF, and MIG levels in both serum and saliva did not differ significantly among the groups. Conclusions: Serum levels of calprotectin and MMP-8 are elevated in patients with AgP. MMP-8 levels are also increased in saliva from patients with AgP. These results support involvement of innate immune response in the pathogenesis of AgP.Swedish Research CouncilSwedish Research Council [2012-07110]This work was supported by the institutional funds (VOO, GE, NB, EAB). Elisabeth A. Bostrom is the recipient of a grant for a part-time position in clinical research environment from the Swedish Research Council (2012-07110). The authors report no conflicts of interest related to this study